Novavax's fourth-quarter loss narrowed on Thursday, helped by reduced selling and administrative expenses of COVID-19 ...
House Republicans are urging President Trump to use executive action on COVID-19 mandates for organ transplants.
Novavax's fourth-quarter loss narrowed on Thursday, helped by reduced selling and administrative expenses of COVID-19 ...
Yale researchers have found clues as to why certain people experience adverse health effects after the COVID-19 vaccine, ...
US federal health officials and experts say there is no evidence that residual DNA from the COVID-19 vaccines can integrate into human DNA ...
In a small study, Yale researchers have found "differences in immune profiles" among those who have rare reaction to the ...
A small study on Covid vaccine safety has sparked an online tempest — and highlighted the conundrum faced by some scientists.
(WIFR) - 2025 marks five years since the deadly COVID-19 pandemic and research shows it impacted how drugs and vaccines are discovered. Phil Mounteney, who is Dotmatics' vice president of science and ...
Novavax reported Q4 sales of $88.31 million, beating estimates despite a decline. The company shifts focus to partnerships ...
An estimated 15 colleges still required Covid vaccines for students as of late last year. No states require K-12 students to ...
Few Minnesotans sought COVID-19 vaccine to reduce their infection risks this winter, but at least the shots offered some protection for those who did. The current vaccine was 33% effective at ...
A recent modification to the contract would have allowed Vaxart to invoice BARDA for the remaining $230 million or so for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results